Identification of biomarker candidates to predict response in the combination immunotherapy for gastric cancer

被引：0
|
作者：
Ohta, Shigeki [1 ,2 ]
Izawa, Naoki [3 ]
Misawa, Aya [1 ,2 ]
Katoh, Yuki [2 ]
Kubo, Akiko [4 ]
Kadowaki, Shigenori [5 ]
Minashi, Keiko [6 ]
Nishina, Tomohiro [7 ]
Eguchi, Takako Nakajima [3 ,8 ]
Kawakami, Yutaka [1 ,2 ]
机构：
[1] IUHW, Sch Med, Dept Immunol, Otawara, Tochigi, Japan
[2] Keio Univ, Sch Med, Inst Adv Med Res, Tokyo, Japan
[3] Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan
[4] Keio Univ, Sch Med, Dept Chem, Tokyo, Japan
[5] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[6] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan
[7] Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan
[8] Kyoto Univ Hosp, Kyoto, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12-5-7
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [31] Response to the rechallenge of combination immunotherapy in a patient with late-stage gastric cancer: case report
    Zhang, Zhening
    Cheng, Siyuan
    Qi, Changsong
    Zhang, Xiaotian
    Peng, Zhi
    Shen, Lin
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (02) : 818 - 826
  • [32] Tumor immune response and immunotherapy in gastric cancer
    Kwak, Yoonjin
    Seo, An Na
    Lee, Hee Eun
    Lee, Hye Seung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2020, 54 (01) : 20 - 33
  • [33] Biomarker of response to immunotherapy
    Nenclares, Pablo
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S7 - S9
  • [34] Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection
    Hashimoto, Itaru
    Kimura, Yayoi
    Oue, Naohide
    Hiroshima, Yukihiko
    Aoyama, Toru
    Rino, Yasushi
    Yokose, Tomoyuki
    Yasui, Wataru
    Miyagi, Yohei
    Oshima, Takashi
    CANCERS, 2022, 14 (18)
  • [35] BiomeOne: multi-center Validation of a new microbiome-based Biomarker to predict Response to Cancer Immunotherapy
    Hochmair, M.
    Schmidinger, M.
    Ay, L.
    Robinson, I.
    Absenger, G.
    Pichler, M.
    Nguyen, V. A.
    Richtig, E.
    Rainer, B.
    Jansen, C.
    Sladek, B.
    Knabl, A.
    Gasche, N.
    Valipour, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 229 - 229
  • [36] BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy
    Robinson, I.
    Schmidinger, M.
    Hochmair, M. J.
    Ay, L.
    Absenger, G.
    Pichler, M.
    Nguyen, V. A. F.
    Richtig, E.
    Rainer, B.
    Jansen, C.
    Sladek, B.
    Knabl, A.
    Gasche, N.
    Valipour, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S592 - S592
  • [37] Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
    Chen, Yan
    Sun, Zepang
    Wan, Li
    Chen, Hongzhuan
    Xi, Tieju
    Jiang, Yuming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
    Chen, Yuan
    Wang, Chengcheng
    Song, Jianlu
    Xu, Ruiyuan
    Ruze, Rexiati
    Zhao, Yupei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] Identification of mRNA signatures that predict response to immunotherapy in melanoma patients
    Vathiotis, Ioannis
    Sullivan, Amy
    Warren, Sarah
    Gianino, Nicole
    Martinez-Morilla, Sandra
    Wong, Pok Fai
    Kluger, Harriet
    Syrigos, Konstantinos
    Rimm, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [40] SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer
    Yu, Pengcheng
    He, Weiyang
    Zhang, Yanqiang
    Hu, Can
    Wu, Yue
    Wang, Yi
    Bao, Zhehan
    Xia, Yuhang
    Zhang, Ruolan
    Cao, Mengxuan
    Yuan, Li
    Cheng, Xiangdong
    Xu, Zhiyuan
    JOURNAL OF ONCOLOGY, 2022, 2022
12345